Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

/p>

369,701$

315,721Collaborative agreement revenues1753556822,379Royalty and license revenues2,9622,7755,8846,556Total revenues101,61487,081376,267324,656OPERATING EXPENSES:Cost of sales (excludes amortization of developed
product technology)20,46916,72970,28565,909Research and development42,19727,443147,309115,116Selling, general and administrative42,09836,528151,723124,290Intangible asset amortization and contingent consideration200—6,4062,914Total operating expenses104,96480,700375,723308,229INCOME (LOSS) FROM CONTINUING OPERATIONS(3,350)6,38154416,427Equity in the loss of BioMarin/Genzyme LLC(797)(821)(2,991)(2,594)Interest income9191,0354,1125,086Interest expense(2,257)(2,715)(10,329)(14,090)Debt conversion expense (13,728)-(13,728)-Impairment loss on equity investments---(5,848)Net gain (loss) from sale of investments(25)-9021,585INCOME (LOSS) BEFORE INCOME TAXES(19,238)3,880(21,490)566Provision for (benefit from) income taxes(7,049)(831)(227,309)1,054NET INCOME (LOSS)$

(12,189)$

4,711$

205,819$

(488)NET INCOME (LOSS) PER SHARE, BASIC$

(0.11)$

0.05$

1.99$

(0.00)NET INCOME (LOSS) PER SHARE, DILUTED$

(0.11)$

0.05$

1.73$

(0.00)Weighted average common shares outstanding, basic107,344100,768103,093100,271Weighted average common shares outstanding, diluted107,344102,454125,674100,271(1) December 31, 2009 balances were derived from the audited consolidated financial statements.Appendix A – Non-GAAP Adjusted EBITDA for 2010 and 2009Reconciliation of GAAP Net Income (Loss) to EBITDA and Adjusted EBITDAFor the Four Quarters and Fiscal Year 2010 (and 2011 Guidance)(in millions)(unaudited) 2010Three Months EndedYear Ended DecemberYear Ending
December 31, 2011NOTESMarch 31June 30September 30December 3131, 2010GuidanceGAAP Net Income/(Loss)$
.2$
(0.5)$
217.3$
(12.2)$
205.8 $(60) - $(48) Interest expense, net1.21.62.01.46.2 6 Income
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 The Haselmeier Group has ... Gert Weber has been nominated by the ... Chief Executive Officer (CEO) of the Haselmeier Group. ... 2015. Mr. Weber brings more than 20 years of ... filled various executive management positions, the last being Managing ...
(Date:6/30/2015)... Calif. , June 30, 2015  The MEDevice ... consecutive year, is an event dedicated to bringing medtech ... hottest issues and topics affecting the industry today. This ... address the challenges and opportunities facing today,s medtech professional ... information and to register for MEDevice San Diego, please ...
(Date:6/30/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, today announced it has submitted its fifth abbreviated ... Drug Administration (FDA) of 2015, which brings the Company,s ... FDA to twenty-seven. Jason Grenfell-Gardner , ... our current pipeline of twenty-seven submissions, exclusive of our ...
Breaking Medicine Technology:Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2
... Technologies, Incorporated (IDEV), an emerging leader in the development and ... named Christopher M. Owens its President and Chief Executive Officer, ... of results-based leadership and is the right person to take ... Anderson. "Chris has a clear vision and strategy of how ...
... Romeo and Juliette Laser Hair Removal on ... in New York City to own the newly introduced Elite ... manufacturer of laser and light-based aesthetic treatment systems. ... technology, is a highly versatile laser aesthetic workstation that combines ...
Cached Medicine Technology:IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer 2Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosure's New Elite MPX(TM) Laser System 2
(Date:7/1/2015)... ... 01, 2015 , ... B. E. Smith, the only full-service ... a national chief executive officer recruitment for Citizens Medical Center in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... ... ... Incentivizing the use of generic drugs has been an easy way for ... 90% off the prices for the brand-name products. But now that generics are experiencing ... of these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s (AIS) ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... global distribution and marketing of a number of nutritional and beauty products, announced ... the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... across platforms and devices, today announced the opening of a new operational office ... and support that enables collaboration across all lines of business for organizations throughout ...
(Date:7/1/2015)... ... 2015 , ... First Harvest Financial , a leading ... legal cannabis startups can interact with corporate executives, serial entrepreneurs and ... looking to strategically enter and capitalize on growing and creating therapeutic cannabis based ...
Breaking Medicine News(10 mins):Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3
... affecting one in 100 people worldwide. Most cases aren,t detected ... as a teenager or adult. By that time, the disease ... to treat. In a paper published recently online by ... University of North Carolina at Chapel Hill and Columbia University ...
... usually about how much of something is due to our ... research just published in the academic journal Addiction ... who smoke, drink, or use drugs, for two related reasons. ... substance use is also predisposed to choose friends who smoke, ...
... Tiger Woods ... is a procedure Dr. Manish Gupta offers at Specialty Orthopedic Center of Boca Raton, FL. ... (PRWEB) June 21, 2010 ... the focus was not on his golf game or his recent lack of. The central ...
... ... ... resident Roger Sencer was driving home from work in May 2009 when he couldn’t remember important ... him to Huntington Hospital. The news was not good: the emergency physician ran tests and ...
... and the University of Ferrara in Italy have collaborated to ... pain without causing many of the side effects of current ... of cancer patients experience pain in the final year of ... use of drugs like morphine produces side effects such as ...
... Multiple sclerosis patients who directly confronted the stress of the ... to cope with the situation by focusing on feelings. This ... researchers of the University of Haifa, the Technion-Israel Institute of ... for multiple sclerosis to date, it is important to uncover ...
Cached Medicine News:Health News:Brain signs of schizophrenia found in babies 2Health News:New research shows peer drug use may increase an individual's genetic tendency to use drugs 2Health News:Tiger Takes Another Shot: PRP Injections Put On the Spot 2Health News:3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor 2Health News:3-D Brain Navigation, Minimally Invasive Surgery Combine to Help Neurosurgeon Remove Tennis Ball-Sized Tumor 3Health News:New drugs to relieve cancer pain 2Health News:Can multiple sclerosis attacks be minimized in a war zone? 2
Tungsten Carbide wire twister....
Designed to have a shock-absorbing force, providing less bounce or wasted force....
Osteophyte periosteal elevator for bone removing....
Angled ring curette....
Medicine Products: